4/26, 7:37 AM (Source: TeleTrader)
more TeleTrader news

Sanofi's Q1 EPS rise 12.3% to €0.91

French pharmaceutical company Sanofi S.A. reported on Friday a rise of 10.9% in business earnings per share (EPS) in the first three months of 2019, amounting to €1.42. At the same time, the IRFS EPS stood at €0.91, marking a 12.3% jump.

The company said its net sales added 6.2% annually to reach €8.39 billion in the last reported quarter. Meanwhile, its net income came in 11.9% higher to total €1.14 billion.

"We executed on key launches in Specialty Care led by the impressive uptake of Dupixent in atopic dermatitis and asthma and also delivered strong growth in Vaccines. At the same time, our new GBU structure enabled us to optimize our growth opportunity in China & Emerging Markets and to adapt to the pressures in Primary Care. Based on our performance in the first quarter, we remain confident in the growth outlook for our business over the rest of the year despite challenging industry dynamics," said Sanofi's CEO Olivier Brandicourt.

Breaking the News / NI